NEW PARKINSON’S DISEASE TREATMENTS IN THE PIPELINE

Parkinson’s Disease (PD) research is ever-changing, with new treatments and medications being...see more explored and developed all the time. Some of the most exciting research initiatives are targeting neuroprotection, as well as motor and non-motor symptoms. As these research projects and clinical trials are underway, the American Parkinson Disease […]

Read More

Hope in Progress: American Parkinson Disease Association Supports Researchers With $2.35 Million in New Funding

From genetic mutations to augmented reality, APDA-funded researchers delve into cutting-edge Parkinson’s research in pursuit of answers   NEW...see more YORK, NY, September 8, 2022 – The American Parkinson Disease Association (APDA) has just awarded $2.35 million to support cutting-edge Parkinson’s disease (PD) research for the 2022-2023 funding year – an increase of more than 25 […]

Read More

Congress Introduces the National Plan to End Parkinson’s Act

On Thursday, July 28, the U.S. House of Representatives introduced a bill entitled the NationalPlan to End Parkinson’s Act...see more and on Thursday September 15, a companion bill was introduced in the Senate. This was an exciting moment for the Parkinson’s disease (PD) community, as this Act acknowledged the need for our government to increase its […]

Read More

American Parkinson Disease Association Expands Support to More Communities with Resources in Simplified Chinese

Two New Resources Will Enable APDA to Reach & Support More People With Parkinson’s NEW YORK, NY, July 6,...see more 2022 – The mission of the American Parkinson Disease Association (APDA) is to provide the support, education, and research to help everyone impacted by Parkinson’s disease (PD) live life to the fullest.  However, it is challenging […]

Read More

APDA-Funded Research Discovers New Role of Alpha Synuclein

In an exciting new study, researchers at Brigham and Women’s Hospital in Boston, MA, led by APDA Cotzias Fellowship*...see more awardee Dr. Vikram Khurana, demonstrated a new role for the protein involved in Parkinson’s disease (PD) pathology, alpha-synuclein. In addition to alpha-synuclein interacting with vesicles, or small transport structures within the cell, this new study shows […]

Read More